Company Analysis IRadimed Corporation
1. Summary
Advantages
- The stock's return over the last year (15.17%) is higher than the sector average (-12.5%).
- Current debt level 2.22% is below 100% and has decreased over 5 years from 4.5%.
- The company's current efficiency (ROE=24.07%) is higher than the sector average (ROE=9.61%)
Disadvantages
- Price (42.59 $) is higher than fair price (17.4 $)
- Dividends (0.4576%) are below the sector average (0.541%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| IRadimed Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 2.5% | -0% |
| 90 days | 11.2% | -17.8% | 2.3% |
| 1 year | 15.2% | -12.5% | 22.3% |
IRMD vs Sector: IRadimed Corporation has outperformed the "Healthcare" sector by 27.67% over the past year.
IRMD vs Market: IRadimed Corporation has significantly underperformed the market by -7.16% over the past year.
Stable price: IRMD is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: IRMD with weekly volatility of 0.2917% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (42.59 $) is higher than the fair price (17.4 $).
Price is higher than fair: The current price (42.59 $) is 59.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (34.28) is lower than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (34.28) is lower than that of the market as a whole (49.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.25) is higher than that of the sector as a whole (4.83).
P/BV vs Market: The company's P/BV (8.25) is higher than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.99) is lower than that of the sector as a whole (33.77).
P/S vs Market: The company's P/S indicator (8.99) is lower than that of the market as a whole (10.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (27.04) is higher than that of the sector as a whole (-22.17).
EV/Ebitda vs Market: The company's EV/Ebitda (27.04) is lower than that of the market as a whole (28.32).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 225.61% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (225.61%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).
5.4. ROE
ROE vs Sector: The company's ROE (24.07%) is higher than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (24.07%) is higher than that of the market as a whole (10.71%).
5.5. ROA
ROA vs Sector: The company's ROA (18.66%) is higher than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (18.66%) is higher than that of the market as a whole (6.47%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4576% is below the average for the sector '0.541%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4576% has been steadily paid over the past 7 years, DSI=0.8.
Weak dividend growth: The company's dividend yield 0.4576% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (76.91%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
